These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020 [TBL] [Abstract][Full Text] [Related]
11. Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation. Kristjansson M; Green P; Manning HL; Slutsky AM; Brecher SM; von Reyn CF; Arbeit RD; Maslow JN Clin Infect Dis; 1993 Aug; 17(2):228-30. PubMed ID: 8104511 [TBL] [Abstract][Full Text] [Related]
12. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma. Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415 [TBL] [Abstract][Full Text] [Related]
13. Mycotic vascular infections of large arteries with Mycobacterium bovis after intravesical bacillus Calmette-Guérin therapy: case report. Seelig MH; Oldenburg WA; Klingler PJ; Blute ML; Pairolero PC J Vasc Surg; 1999 Feb; 29(2):377-81. PubMed ID: 9950996 [TBL] [Abstract][Full Text] [Related]
14. Miliary pulmonary tuberculosis after the first dose of intravesical BCG instillation in a patient with high-grade bladder cancer. Stępień A; Brudło M; Stachura T; Marcinek P; Soja J; Sładek K Adv Respir Med; 2020; 88(6):628-629. PubMed ID: 33393659 [No Abstract] [Full Text] [Related]
15. Pulmonary disease following intravesical BCG treatment. Kesten S; Title L; Mullen B; Grossman R Thorax; 1990 Sep; 45(9):709-10. PubMed ID: 2218978 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy with bacille Calmette-Guérin in patients with superficial transitional cell carcinoma of the bladder associated with bilharziasis. Wishahi MM; Ismail IM; el-Sherbini M Br J Urol; 1994 Jun; 73(6):649-54. PubMed ID: 8032832 [TBL] [Abstract][Full Text] [Related]
17. Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guérin) in superficial bladder cancer. Rintala E; Jauhiainen K; Alfthan O; Hansson E; Juusela H; Kanerva K; Korhonen H; Permi J; Sotarauta M; Vaalasti T Eur Urol; 1991; 20(1):19-25. PubMed ID: 1743226 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer. Lamm DL Clin Infect Dis; 2000 Sep; 31 Suppl 3():S86-90. PubMed ID: 11010830 [TBL] [Abstract][Full Text] [Related]
19. [Granulomatous pneumonia as a complication of intravesical BCG immunotherapy--a case report]. Rogoziński P; Taracha-Guz D; Pęcikiewicz P; Kachel T; Dubiel G; Wandzel P; Bruliński K Pneumonol Alergol Pol; 2014; 82(2):163-9. PubMed ID: 24615200 [TBL] [Abstract][Full Text] [Related]
20. Disseminated infection after bacille Calmette-Guérin instillation for treatment of bladder carcinoma. Viallard JF; Denis D; Texier-Maugein J; Parrens M; Faure I; Pellegrin JL; Leng B Clin Infect Dis; 1999 Aug; 29(2):451-2. PubMed ID: 10476764 [No Abstract] [Full Text] [Related] [Next] [New Search]